Category Specific RSS

News

Carly Holdings’ EV Trial targets aspiring EV buyers

Most consumers love ‘try before you buy’ opportunities, especially when the goods or services involved are big ticket items laden…

3 years ago

Can cannabis cure insomnia? Avecho gets ethics approval to test in Phase 3 trials

For many, a bad night’s sleep can be chalked up to a late night out, stress and such. However, multiple…

3 years ago

Tourism Holding divests share in Camplify due to lack of return on funds

On the heels of a mixed recreational vehicles (RVs) market, global tourism operator Tourism Holdings Limited (ASX: THL) has finalised…

3 years ago

Rent.com.au expands RentPay to include digital wallets to meet demand for flexible payment options

With more than 500,000 migrants arriving in Australia annually, most on student and working visas quickly find that housing becomes…

3 years ago

Atomo’s HIV self-test kits head to low income countries with $970k Viatris order

Medical device company Atomo Diagnostics (ASX: AT1) has locked in purchase orders from Viatris Healthcare Pty Ltd amounting to approximately…

3 years ago

Zoono and OSY team up to tackle food waste in exclusive agreement

Despite global efforts, food waste remains a challenging problem to solve. Each year, 1.3 billion tons of food is wasted…

3 years ago

Cynata recruits first patient for Phase 2 trial of stem cells for graft vs host disease

Aussie clinical stage biotech company Cynata Therapeutics (ASX: CYP) has marked a milestone in its Phase 2 clinical trial of…

3 years ago

Revasum extends voluntary suspension in pursuit of takeover offer

While the artificial intelligence industry has been a big winner from the bumper financials delivered by semiconductor company NVIDIA last…

3 years ago

Beforepay launches Carrington Labs, aims to revolutionise B2B lending with artificial intelligence modelling

With a name that evoked interest amid the Buy-Now-Pay-Later boom led by Afterpay, it came as no surprise that Beforepay…

3 years ago

Cost reductions, new management and more: Jayride’s strategic review brings hope

Online travel aggregator Jayride (ASX: JAY) had little choice but to undertake a comprehensive strategic review following dwindling profit margins.…

3 years ago